Publication:
Prognostic factors of breast phyllodes tumors

Thumbnail Image
Files
c9b7e337-b441-4a7a-ac32-2855eba0e75f.pdf(4.18 MB)
Date
2023
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Shin, Eunah ; Koo, Ja Seung
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-600
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Background. Phyllodes tumor (PT) is a relatively rare breast tumor, accounting for <1% of all breast tumors. Main body. Adjuvant therapy with chemotherapy or radiation therapy, other than surgical excision, has not been established yet. PT, similar to other breast tumors, is classified as benign, borderline, and malignant according to the World Health Organization classification system, depending on stromal cellularity, stromal atypia, mitotic activity, stromal overgrowth, and tumor border. However, this histological grading system cannot effectively or fully reflect the clinical prognosis of PT. Several studies have investigated prognostic factors for PT as some PTs recur or metastasize to distant sites, and thus, prediction of prognosis is clinically imperative. Conclusion. This review discusses clinicopathological factors, immunohistochemical markers, and molecular factors that have been investigated in previous studies to have an impact on the clinical prognosis of PT.
publication.page.subject
Breast , Prognosis , Phyllodes tumor
Citation
Histology and Histopathology Vol. 38, nº8 (2023)
URI
http://hdl.handle.net/10201/133728
item.page.embargo
Collections
Histology and histopathology Vol.38, nº8 (2023)
Ir a Estadísticas